Tiziana Life Sciences Announces Agreement with STC Biologics for GMP Manufacturing of an anti-Interleukin-6-Receptor Monoclonal Antibody for Clinical Studies in Patients with COVID-19.
Share Talk Bulletin Board Heroes, Thursday 25th June 2020
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this video charting update.
Share Talk Bulletin Board Heroes, Friday 19th June 2020
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this video charting update.
Tiziana Life Sciences (TILS.TLSA.L) Granted First-Ever Patent on a Transformational Technology
Technology for Oral Delivery of all Anti-CD3 Monoclonal Antibodies for Treatment of Human Diseases
Share Talk Bulletin Board Heroes – Pharma Special, 16th June 2020
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this charting update. Here is our pick of
TIZIANA LIFE SCI PLC (TILS.L) Extension of At the Market Sales Agreement
Tiziana Life Sciences plc (AIM:TILS) is pleased to announce the agreement of an extension to the current At the Market Sales Agreement with ThinkEquity, a division of Fordham Financial Management,
Share Talk Bulletin Board Heroes, Wednesday 10th June 2020
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this video charting update.
Share Talk Bulletin Board Heroes, Friday 29th May 2020
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this video charting update.
Tiziana Life Sciences (TILS.L) announces presentation of StemPrintER
A superior prognostic test as compared to Oncotype DX to predict breast cancer
Bank Holiday Bulletin Board Heroes, Pharma Special, Saturday 23rd May 2020
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this charting update. Here is our bank holiday
Tiziana Life Sciences (TILS.L) Demerge Its StemPrintER Genomics-Based Personalized Medicine Business
Tiziana Lifesciences Announces Intention to Demerge Its StemPrintER Genomics-Based Personalized Medicine Business as a Separate Listed Company
Share Talk Bulletin Board Heroes, Thursday 14th May 2020
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this video charting update.